AR046719A1 - Sales de benzazepina y composiciones farmacéuticas que las contienen. - Google Patents

Sales de benzazepina y composiciones farmacéuticas que las contienen.

Info

Publication number
AR046719A1
AR046719A1 ARP040104393A ARP040104393A AR046719A1 AR 046719 A1 AR046719 A1 AR 046719A1 AR P040104393 A ARP040104393 A AR P040104393A AR P040104393 A ARP040104393 A AR P040104393A AR 046719 A1 AR046719 A1 AR 046719A1
Authority
AR
Argentina
Prior art keywords
contain
pharmaceutical compositions
salts
benzazepine
chlorobenzyloxy
Prior art date
Application number
ARP040104393A
Other languages
English (en)
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR046719A1 publication Critical patent/AR046719A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ARP040104393A 2003-11-28 2004-11-26 Sales de benzazepina y composiciones farmacéuticas que las contienen. AR046719A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds

Publications (1)

Publication Number Publication Date
AR046719A1 true AR046719A1 (es) 2005-12-21

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104393A AR046719A1 (es) 2003-11-28 2004-11-26 Sales de benzazepina y composiciones farmacéuticas que las contienen.

Country Status (18)

Country Link
US (1) US20070275948A1 (cg-RX-API-DMAC7.html)
EP (1) EP1687279A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007512285A (cg-RX-API-DMAC7.html)
KR (1) KR20060103322A (cg-RX-API-DMAC7.html)
CN (1) CN1906170A (cg-RX-API-DMAC7.html)
AR (1) AR046719A1 (cg-RX-API-DMAC7.html)
AU (1) AU2004293179A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0417029A (cg-RX-API-DMAC7.html)
CA (1) CA2547444A1 (cg-RX-API-DMAC7.html)
GB (1) GB0327740D0 (cg-RX-API-DMAC7.html)
IL (1) IL175663A0 (cg-RX-API-DMAC7.html)
IS (1) IS8500A (cg-RX-API-DMAC7.html)
MA (1) MA28177A1 (cg-RX-API-DMAC7.html)
NO (1) NO20062970L (cg-RX-API-DMAC7.html)
RU (1) RU2006122959A (cg-RX-API-DMAC7.html)
TW (1) TW200528433A (cg-RX-API-DMAC7.html)
WO (1) WO2005051916A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200603781B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
EP2240466B1 (en) * 2008-01-08 2015-07-29 Merck Sharp & Dohme Limited Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide
US20180228811A1 (en) * 2014-12-12 2018-08-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
US12297184B2 (en) 2018-10-03 2025-05-13 Tesaro, Inc. Niraparib salts
CN116406268A (zh) * 2020-10-27 2023-07-07 特维娜有限公司 δ-阿片样物质调节剂的结晶和无定形形式
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1456178A1 (en) * 2001-12-21 2004-09-15 Smithkline Beecham Plc 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
PL371344A1 (en) * 2002-02-13 2005-06-13 Glaxo Group Limited Benzenesulfonamide derivatives as antipsychotic agents
MY133587A (en) * 2002-05-29 2007-11-30 Glaxo Group Ltd Aromatic sulfones and their medical use

Also Published As

Publication number Publication date
WO2005051916A1 (en) 2005-06-09
CN1906170A (zh) 2007-01-31
US20070275948A1 (en) 2007-11-29
EP1687279A1 (en) 2006-08-09
JP2007512285A (ja) 2007-05-17
TW200528433A (en) 2005-09-01
IS8500A (is) 2006-06-08
ZA200603781B (en) 2007-09-26
MA28177A1 (fr) 2006-09-01
AU2004293179A1 (en) 2005-06-09
IL175663A0 (en) 2006-09-05
CA2547444A1 (en) 2005-06-09
RU2006122959A (ru) 2008-01-10
GB0327740D0 (en) 2003-12-31
BRPI0417029A (pt) 2007-02-06
NO20062970L (no) 2006-08-21
KR20060103322A (ko) 2006-09-28

Similar Documents

Publication Publication Date Title
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
IL149163A0 (en) Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
DK1263730T3 (da) Aminderivater til behandling af apoptose
EA200702498A1 (ru) N-(пиридин-2-ил)сульфонамидные производные
DE122009000026I1 (de) Als carbohydrase-inhibitoren verwendbare thiophen sulfonamide
ECSP034914A (es) "azaindoles"
AR035714A1 (es) Pirazoles sustituidos y composiciones farmaceuticas que los contienen
EA200700185A1 (ru) Производные хиназолиндиона в качестве ингибиторов parp
NO20032905L (no) Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister
DE60330187D1 (de) Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
UY27446A1 (es) Nuevos compuestos
CL2004000788A1 (es) Compuestos derivados de n-[2-oxo-6-(aril o heteroaril)azepan-3-il]-4-(2-oxo-2,3-dihidro-1h-imidazo[4,5-b]piridin-1-il)piperidina-1-carboxamida, antagonistas de los receptores cgrp; composicion farmaceutica; y uso del compuesto en el tratamiento del d
UY26704A1 (es) Nueva composición farmacéutica
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
ATE394383T1 (de) Biphenylkarbonsäureamidderivate als p38 kinase- inhibitoren
MXPA03006224A (es) Inhibidores de cruzipaina y otras proteasas de cisteina.
BR0208741A (pt) Derivados de piperidina
FI970317A0 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
SE0403171D0 (sv) New compounds
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
DE60313350D1 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
CO5690551A2 (es) Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo
ATE516016T1 (de) Selbstemulgierende formulierungen von cetp- hemmern

Legal Events

Date Code Title Description
FA Abandonment or withdrawal